Neogen CORP Form 4 insider transactions

NEOGEN Director Ronald D Green converted 1,777 Restricted Stock Units into common stock at $6.19 per share, increasing his direct holdings.

NEOGEN Director Aashima Gupta converted 1,777 Restricted Stock Units into common stock on October 27, 2025, increasing her direct beneficial ownership to 27,790 shares.

NEOGEN Director Rafael A. Rodriguez acquired 1,777 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James P. Tobin converted 1,777 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 43,347 shares.

NEOGEN Director Catherine E Woteki converted 1,777 Restricted Stock Units into common stock on October 27, 2025, increasing her direct beneficial ownership to 19,117 shares.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of Restricted Stock Units and subsequent stock transactions.

NEOGEN's Chief Financial Officer, David H. Naemura, increased his direct beneficial ownership of common stock by a net of 11,243 shares following the vesting of Restricted Stock Units and subsequent tax withholding.

Douglas Edward Jones, former COO of NEOGEN CORP, exercised 15,504 Restricted Stock Units and sold a portion for tax withholding.

Former NEOGEN CEO John Edward Adent exercised 38,759 Restricted Stock Units, resulting in a net acquisition of 30,232 common shares after tax withholding.

NEOGEN Director William T. Boehm converted 3,553 Restricted Stock Units into common stock on October 27, 2025, increasing his direct beneficial ownership.

NEOGEN Director Jeffrey D. Capello converted 2,025 Restricted Stock Units into common stock on October 27, 2025, increasing his direct ownership.

NEOGEN Director James C. Borel converts 2,025 Restricted Stock Units into common stock.

NEOGEN Director Avi Pelossof reported the acquisition of 19,386 shares of common stock and 49,929 derivative securities, effective October 24, 2025.

NEOGEN Director Catherine E Woteki acquired 19,769 shares of common stock and 50,814 derivative securities (rights to buy) on October 23, 2025.

NEOGEN Director Andrea F Wainer acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

NEOGEN Director Rafael A. Rodriguez acquired 19,769 shares of common stock and 50,814 derivative securities at $6.07 per share, increasing his beneficial ownership.

NEOGEN Director Aashima Gupta reported the acquisition of 19,769 shares of common stock and 50,814 derivative securities (rights to buy common stock) at an exercise price of $6.07, effective October 23, 2025.

NEOGEN Corp. Director Ronald D. Green reported the acquisition of 19,769 shares of common stock and 50,814 derivative securities on October 23, 2025.

NEOGEN Director Jeffrey D. Capello acquired additional common stock and derivative securities, increasing his beneficial ownership.

NEOGEN Director Thierry Bernard acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

NEOGEN Corp. Director James C. Borel acquired 19,769 shares of common stock and 50,814 derivative securities, signaling confidence.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting and settlement of 294 Restricted Stock Units into common stock, followed by a sale of 115 shares for tax purposes.

Douglas Edward Jones, former COO of NEOGEN CORP, reported the vesting of Restricted Stock Units and subsequent adjustment of his common stock holdings.

NEOGEN's former CEO, John Edward Adent, reported the scheduled vesting and settlement of Restricted Stock Units into common stock, followed by a disposition for tax purposes.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of 9,036 Restricted Stock Units and a subsequent sale of 3,534 shares for tax purposes on October 7, 2025.

Douglas Edward Jones, former COO of NEOGEN CORP, reported the vesting and settlement of Restricted Stock Units and subsequent disposition of shares for tax purposes.

Former NEOGEN CEO John Edward Adent exercised Restricted Stock Units, acquiring 32,936 shares of common stock and disposing of 9,297 shares for tax purposes.

NEOGEN Director Catherine E. Woteki acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James P. Tobin converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 39,545 shares.

NEOGEN Director Rafael A. Rodriguez converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 17,019 shares.